SC
NRC icon

Spitfire Capital’s NRC Health Common Stock NRC Stock Holding History

Spitfire Capital’s Portfolio NRC Stock Details NRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$2.3M Sell
39,784
-70,167
-64% -$4.35M 2.98% 14
2019
Q2 		$6.33M Sell
109,951
-5,988
-5% -$277K 6.63% 4
2019
Q1 		$4.47M Sell
115,939
-10,694
-8% -$419K 4.68% 11
2018
Q4 		$4.83M Sell
126,633
-104,196
-45% -$4M 5.42% 9
2018
Q3 		$8.91M Sell
230,829
-118,047
-34% -$4.48M 4.63% 10
2018
Q2 		$13M Buy
348,876
+47,886
+16% +$1.67M 6.27% 5
2018
Q1 		$8.8M Hold
300,990
– – 4.15% 12
2017
Q4 		$11.2M Sell
300,990
-9,465
-3% -$336K 4.97% 9
2017
Q3 		$11.7M Sell
310,455
-128,980
-29% -$4.05M 4.88% 7
2017
Q2 		$11.8M Sell
439,435
-214,162
-33% -$5.24M 5.5% 6
2017
Q1 		$12.9M Sell
653,597
-104,820
-14% -$1.94M 6.31% 5
2016
Q4 		$14.4M Sell
758,417
-101,364
-12% -$1.67M 6.52% 4
2016
Q3 		$14M Sell
859,781
-32,818
-4% -$515K 6.24% 4
2016
Q2 		$12.2M Sell
892,599
-600
-0.1% -$8.46K 5.69% 3
2016
Q1 		$13.9M Sell
893,199
-29,025
-3% -$425K 6.41% 3
2015
Q4 		$14.8M Sell
922,224
-1,412
-0.2% -$21.4K 6.82% 4
2015
Q3 		$11M Buy
923,636
+27,387
+3% +$364K 4.74% 9
2015
Q2 		$12.7M Buy
896,249
+148,151
+20% +$2.1M 4.89% 5
2015
Q1 		$10.8M Buy
748,098
+51,023
+7% +$721K 4.5% 6
2014
Q4 		$9.75M Buy
697,075
+2,811
+0.4% +$41.3K 4.52% 8
2014
Q3 		$9.03M Buy
694,264
+11,965
+2% +$165K 4.55% 8
2014
Q2 		$9.54M Buy
682,299
+212,225
+45% +$3.19M 4.84% 7
2014
Q1 		$7.8M Buy
470,074
+67,065
+17% +$1.12M 4.53% 9
2013
Q4 		$7.58M Buy
+403,009
New +$7.07M 5.12% 8

Other funds holding NRC

Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Spitfire Capital's NRC Position: Q3 2019 in Review

Spitfire Capital reduced its NRC Health Common Stock (NRC) stake by 64% in Q3 2019, selling an estimated $4.35M and leaving 39,784 shares worth $2.3M. The position accounts for 2.98% of the portfolio, ranked #14.

Spitfire Capital first reported a position in NRC in Q4 2013 and has held it in 24 quarters since. The position peaked at $14.8M in Q4 2015. 96 funds tracked by Wall St. Rank hold NRC as of Q3 2019.

  • Spitfire Capital held 39,784 shares of NRC Health Common Stock worth $2.3M as of Q3 2019.
  • Spitfire Capital sold 70,167 NRC Health Common Stock shares in Q3 2019, an estimated $4.35M.
  • NRC Health Common Stock made up 2.98% of Spitfire Capital's portfolio in Q3 2019, its #14 holding.
  • Spitfire Capital first reported a position in NRC Health Common Stock in Q4 2013 and has held it in 24 quarters since.
  • Spitfire Capital's NRC Health Common Stock position peaked at $14.8M in Q4 2015.
  • 96 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q3 2019.

Based on Spitfire Capital's 13F filing for Q3 2019, filed 14 Nov 2019.